Zacks.com on MSN17h
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...
emjreviews.com21h
GSK pursues co-administration of RSV and shingles vaccines
GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...
The greatest British shares to invest in: Their steady and dependable growth is a testament to the power of UK plc
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
BioSpace1d
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
However, sales have been slowing. In the second quarter of this year, GSK reported that Shingrix sales dropped 4% ...
FiercePharma1d
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...
FiercePharma1d
AstraZeneca's Fasenra plays catch-up with GSK's Nucala, gaining FDA nod for rare autoimmune disease
Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two ... Fasenra has been shut out in its attempts to expand to new ...
WTAQ2d
GSK’s RSV vaccine meets main goal when co-administered with shingles shot
(Reuters) – British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with ...